What sector does Select Medical Holdings, Corp. belong to?

Select Medical Holdings, Corp. operates in the Health Care sector, specifically the Health Care Facilities industry, and is listed on the US markets.

What is the P/E ratio of SEM?

Select Medical Holdings, Corp. has a price-to-earnings (P/E) ratio of about 14.23. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of SEM?

The market capitalisation of Select Medical Holdings, Corp. is approximately $2.08B.

Is Select Medical Holdings, Corp. profitable?

For its latest reported financial year, Select Medical Holdings, Corp. recorded a net profit margin of about 2.68%.

What is the return on equity (ROE) of SEM?

Select Medical Holdings, Corp. has a return on equity (ROE) of about 8.33%. ROE measures how much profit a company generates relative to shareholders' equity.

Select Medical Holdings, Corp.

SEM US Health Care Health Care Facilities

S&P 600

Fair value analysis

SEM

$16.51

Close used for this calculation

$21.59Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

51/100

Profitability9/25

Returns15/25

Balance Sheet9/25

Efficiency18/25

Growth12/25

Good

Quality radar

Consensus fair value

$21.59

Below FV

▲ +30.8% against the close used

Model range $2.59 – $42.01

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$2.59Fair value$21.59Bull$42.01

FairClose

52-week traded range

52W low $11.7752W high $16.66

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Select Medical Holdings, Corp. closed at $16.51, 23.5% below the consensus fair value of $21.59 drawn from 9 valuation models.

Financial DNA score 51/100 — Good. P/E of 14.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$12.50

-24.3%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=2.2%, r=10%, tg=3%, n=10yr

Graham Number

$19.53

+18.3%

√(22.5 × EPS × BVPS)

EPS=1.16, BVPS=14.61

P/E Fair Value

$23.20

+40.5%

EPS × 20x (sector P/E)

EPS=1.16, Sector P/E=20x

Peter Lynch (PEG)

$2.59

-84.3%

EPS × Growth% (PEG = 1 is fair)

EPS=1.16, g=2.2%

EV/EBITDA

$42.01

+154.5%

(EBITDA × 11.1x − Net Debt) ÷ Shares

EBITDA=476.47M

Dividend Discount (DDM)

$3.28

-80.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=0.25, r=10%, g=2.2%

Book Value (P/B)

$11.12

-32.6%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=14.61, ROE=8.3%, g=3%, r=10%

Reverse DCF

$16.51

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 2.5% | Historical: 2.2%

Margin of Safety

$13.81

-16.4%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=18.41, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer